Cleared Traditional

K223469 - WallFlex™ Biliary RX Stent System (FDA 510(k) Clearance)

Jun 2023
Decision
210d
Days
Class 2
Risk

K223469 is an FDA 510(k) clearance for the WallFlex™ Biliary RX Stent System. This device is classified as a Stents, Drains And Dilators For The Biliary Ducts (Class II - Special Controls, product code FGE).

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on June 15, 2023, 210 days after receiving the submission on November 17, 2022.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5010.

Submission Details

510(k) Number K223469 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received November 17, 2022
Decision Date June 15, 2023
Days to Decision 210 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code FGE — Stents, Drains And Dilators For The Biliary Ducts
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5010

Similar Devices — FGE Stents, Drains And Dilators For The Biliary Ducts

All 10
Disposable Balloon Catheter (B5-2Q)
K250409 · Olympus Medical Systems Corporation · Oct 2025
Advanix™ Pancreatic Stent and NaviFlex™ Rapid Exchange (RX) Pancreatic Delivery System and Pushers
K251291 · Boston Scientific · Jul 2025
Tornus ES
K241801 · Asahi Intecc Co., Ltd. · Dec 2024
WallFlex Biliary PLUS RX Stent System
K242950 · Boston Scientific · Dec 2024
WallFlex Biliary RX Stent System
K240464 · Boston Scientific · Aug 2024
Zimmon® Pancreatic Stents/Stent sets (SPSOF, SPSOS, ZEPDF, ZEPDS, ZPSOF, ZPSOS)
K233079 · Cook Ireland, Ltd. · Jun 2024